80 related articles for article (PubMed ID: 21621468)
1. Effects of oligodeoxynucleotide with CCT repeats on chronic graft versus host disease induced experimental lupus nephritis in mice.
He C; Zhou L; Sun R; Zhao T; Zhang Y; Fu Y; Wang L; Yu Y
Clin Immunol; 2011 Sep; 140(3):300-6. PubMed ID: 21621468
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of a guanine-free oligodeoxynucleotide as immunopotent inhibitor.
Zhang YS; Wu XL; Wang Y; Sun R; Yu YL; Wang LY
Int Immunopharmacol; 2012 Aug; 13(4):446-53. PubMed ID: 22664144
[TBL] [Abstract][Full Text] [Related]
3. Characterization of reactivity of monoclonal autoantibodies with renal antigens in experimental lupus nephritis.
Kootstra JC; Veninga A; Baelde JJ; van Eendenburg J; de Heer E; Bruijn JA
J Clin Lab Immunol; 1996; 48(5):201-18. PubMed ID: 9394243
[TBL] [Abstract][Full Text] [Related]
4. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney.
Zhang JL; Sun DJ; Hou CM; Wei YL; Li XY; Yu ZY; Feng JN; Shen BF; Li Y; Xiao H
Transpl Immunol; 2010 Oct; 24(1):17-25. PubMed ID: 20850528
[TBL] [Abstract][Full Text] [Related]
5. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels.
Maeda T; Nomoto K
J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559
[TBL] [Abstract][Full Text] [Related]
6. TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis.
Molano A; Lakhani P; Aran A; Burkly LC; Michaelson JS; Putterman C
Immunol Lett; 2009 Aug; 125(2):119-28. PubMed ID: 19573558
[TBL] [Abstract][Full Text] [Related]
7. A human microsatellite DNA-mimicking oligodeoxynucleotide with CCT repeats negatively regulates TLR7/9-mediated innate immune responses via selected TLR pathways.
Sun R; Sun L; Bao M; Zhang Y; Wang L; Wu X; Hu D; Liu Y; Yu Y; Wang L
Clin Immunol; 2010 Mar; 134(3):262-76. PubMed ID: 20034855
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic MHC antigen requirements for lupus-like autoantibody production and nephritis in murine graft-vs-host disease.
Portanova JP; Ebling FM; Hammond WS; Hahn BH; Kotzin BL
J Immunol; 1988 Nov; 141(10):3370-6. PubMed ID: 3263424
[TBL] [Abstract][Full Text] [Related]
9. Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis.
Quezada SA; Eckert M; Adeyi OA; Schned AR; Noelle RJ; Burns CM
Arthritis Rheum; 2003 Sep; 48(9):2541-54. PubMed ID: 13130474
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody against CD86 and its protection in a murine lupus nephritis model of chronic graft-versus-host disease.
Han L; Shen L; Zhu Y; Qiu Y
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):285-291. PubMed ID: 28747139
[TBL] [Abstract][Full Text] [Related]
11. Association between leukocyte infiltration and development of glomerulosclerosis in experimental lupus nephritis.
Kootstra CJ; Sutmuller M; Baelde HJ; de Heer E; Bruijn JA
J Pathol; 1998 Feb; 184(2):219-25. PubMed ID: 9602715
[TBL] [Abstract][Full Text] [Related]
12. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
13. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
14. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
[TBL] [Abstract][Full Text] [Related]
15. An oligodeoxynucleotide capable of lessening acute lung inflammatory injury in mice infected by influenza virus.
Fang M; Wan M; Guo S; Sun R; Yang M; Zhao T; Yan Y; Zhang Y; Huang W; Wu X; Yu Y; Wang L; Hua S
Biochem Biophys Res Commun; 2011 Nov; 415(2):342-7. PubMed ID: 22033400
[TBL] [Abstract][Full Text] [Related]
16. Redistribution of glomerular dipeptidyl peptidase type IV in experimental lupus nephritis. Demonstration of decreased enzyme activity at the ultrastructural level.
van Leer EH; Bruijn JA; Prins FA; Hoedemaeker PJ; de Heer E
Lab Invest; 1993 May; 68(5):550-6. PubMed ID: 8098785
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of laminin chains and anti-laminin autoantibodies in experimental lupus nephritis.
Peutz-Kootstra CJ; Hansen K; De Heer E; Abrass CK; Bruijn JA
J Pathol; 2000 Nov; 192(3):404-12. PubMed ID: 11054725
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ
Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389
[TBL] [Abstract][Full Text] [Related]
20. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
